MRO Magazine

Cloud-based Automation Solutions Will Significantly Drive the Adoption of Industrial Automation in Life Sciences Industry Until 2020, Says Technavio

May 12, 2016 | By Business Wire News

LONDON

According to the latest research study released by Technavio, the global industrial automation in life sciences industry is expected reach USD 5.13 billion by 2020.

This research report titled ‘Global Industrial Automation Market in Life Sciences Industry 2016-2020’, provides an in-depth analysis of market growth in terms of revenue and emerging market trends. To calculate the market size, Technavio researchers have considered revenues generated from the sales and aftermarket services of programmable logic controllers (PLCs), manufacturing execution systems (MES), supervisory control and data acquisition (SCADA), and distributed control system (DCS).

Request sample report: http://bit.ly/24BcPkx

“The life sciences industry is using cloud technologies to improve genomic research, open innovation, and collaboration. Cloud adoption is achieved through the adoption of MMS, CMS, ERP, DCS, SCADA, and PLC systems. Cloud-based software-as-a-service is likely to become the next logical step in the evolution of automation technology in the life sciences industry,” said Bharath Kanniappan, one of Technavio’s lead analysts for automation research.

“Life sciences companies are becoming more comfortable with the concept of service-based technology architecture. Thanks to the shift towards a more cloud-based environment, they are expected to incur immense benefits such as reduced costs, greater flexibility, and enhanced functionalities,” added Bharath.

Global industrial automation market in life sciences industry by product 2015

  • DCS 35.59%
  • SCADA 31.78%
  • MES 13.46%
  • PLC 19.17%

Source: Technavio research

Global industrial automation market in life sciences industry by DCS

The global industrial automation market in the life sciences industry by DCS was valued at USD 1.4 billion in 2015. The pharmaceutical industry worldwide is expanding rapidly to meet the needs of the global population.

Endemic tropical infections and chronic lifestyle disorders, such as diabetes and hypertension, have spiked mortality rates, especially in the urban population. Chronic diseases are responsible for seven out of 10 deaths each year in the US and therefore occupies close to 84% of the country’s healthcare costs. Therefore, many companies are predicted to invest heavily in medical R&D in this region.

Also, with governments in emerging countries enforcing many new legislations and health for providing essential treatment and medicines at affordable prices, the life sciences industry is anticipating further modernization to meet these requirements over the next four years.

Technavio researchers predict a significant rise in the demand for automation solutions such as DCS from the pharmaceutical industry, in emerging countries, such as India, China, Brazil, Malaysia, and Indonesia, during the forecast period. This demand is expected to stem from high domestic and foreign demand for pharmaceutical products.

Global industrial automation market in life sciences industry by MES

The global industrial automation market in the life sciences industry by MES was valued at USD 529.2 million in 2015. MES is an electronic interface between orders, equipment and processing instructions (batch records), personnel, and logistics. MES in the life sciences industry mediates between business administration functions (planning, control, production, and sales) and automation of production processes. MES controls, optimizes, and documents processes executed at the shop floor in compliance with pharmaceutical requirements. It is likely to find increased suitability in chemical manufacturing of APIs and processing of APIs that are in solid and pharmaceutical forms. It is also anticipated to help companies improve batch processing and packaging operations.

Global industrial automation market in life sciences industry by PLC

The global industrial automation market in the life sciences industry by PLC was valued at USD 753.86 million in 2015. PLC controls drug manufacturing equipment and is connected to the central processing system. Control software packages use ladder logic, functional block diagrams, and sequential function charts for embedding these programs into PLCs. These programs are documented and updated in order to improve the plant’s productivity. The market comprises multiple large, regional, and local vendors who are expected to offer standard as well as customized products to satisfy unique customer needs.

Browse related reports:

Purchase these three reports for the price of one by becoming a Technavio subscriber. Subscribing to Technavio’s reports allows you to download any three reports per month for the price of one. Contact enquiry@technavio.com with your requirements and a link to our subscription platform.

About Technavio

Technaviois a leading global technology research and advisory company. The company develops over 2000 pieces of research every year, covering more than 500 technologies across 80 countries. Technavio has about 300 analysts globally who specialize in customized consulting and business research assignments across the latest leading edge technologies.

Technavio analysts employ primary as well as secondary research techniques to ascertain the size and vendor landscape in a range of markets. Analysts obtain information using a combination of bottom-up and top-down approaches, besides using in-house market modeling tools and proprietary databases. They corroborate this data with the data obtained from various market participants and stakeholders across the value chain, including vendors, service providers, distributors, re-sellers, and end-users.

If you are interested in more information, please contact our media team at media@technavio.com.

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 630 333 9501
UK: +44 208 123 1770
www.technavio.com
media@technavio.com

Stories continue below
Print this page